Hydrochloric Acid → HCID 58614658, compound
Reaction equation
Cl.[Cl:2][C:3]1[CH:8]=[CH:7][C:6]([NH:9][C:10](=[O:25])[C:11]2[CH:16]=[CH:15][C:14]([CH2:17][N:18]3[CH2:23][CH2:22][NH:21][CH2:20][C:19]3=[O:24])=[CH:13][CH:12]=2)=[CH:5][C:4]=1[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][N:27]=1.C=O.[C:34](O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>CC(O)=O.CN(C=O)C>[Cl:2][C:3]1[CH:8]=[CH:7][C:6]([NH:9][C:10](=[O:25])[C:11]2[CH:12]=[CH:13][C:14]([CH2:17][N:18]3[CH2:23][CH2:22][N:21]([CH3:34])[CH2:20][C:19]3=[O:24])=[CH:15][CH:16]=2)=[CH:5][C:4]=1[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][N:27]=1Participants
7
Procedure
To 200 mg of the HCl salt of N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-((2-oxopiperazin-1-yl)methyl)benzamide was added 55 mg of Paraformaldehyde and 185 mg of Sodium Triacetoxyborohydride in 1 mL of 2% AcOH in DMF. After completion, the reaction is extracted once with bicarbonate and brine in Ethyl Acetate, dried over Magnesium Sulfate, concentrated and purified by reverse phase HPLC to give pure N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-((4-methyl-2-oxopiperazin-1-yl)methyl)benzamide. MS (Q1) 435.3 (M)+.
Workup
- extractionAfter completion, the reaction is extracted once with bicarbonate and brine in Ethyl Acetate
- dry with materialdried over Magnesium Sulfate
- concentrationconcentrated
- custompurified by reverse phase HPLC
Sources & evidence
- ORD record
- ord-6eedfc7d19284df8a00553dfadded0fc
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09278961B2
Reaction notes
Loading…